Canada Markets closed

Takeda Pharmaceutical Company Limited (TAK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
13.00-0.16 (-1.22%)
At close: 04:00PM EDT
13.00 0.00 (0.00%)
After hours: 07:58PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.81
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 317.07
52 Week Low 312.87
50-Day Moving Average 313.93
200-Day Moving Average 314.27

Share Statistics

Avg Vol (3 month) 32.4M
Avg Vol (10 day) 32.74M
Shares Outstanding 53.12B
Implied Shares Outstanding 6N/A
Float 82.99B
% Held by Insiders 10.01%
% Held by Institutions 11.87%
Shares Short (Jul 14, 2022) 44.18M
Short Ratio (Jul 14, 2022) 41.64
Short % of Float (Jul 14, 2022) 4N/A
Short % of Shares Outstanding (Jul 14, 2022) 40.13%
Shares Short (prior month Jun 14, 2022) 44.06M

Dividends & Splits

Forward Annual Dividend Rate 40.8
Forward Annual Dividend Yield 45.50%
Trailing Annual Dividend Rate 3180.00
Trailing Annual Dividend Yield 31,367.78%
5 Year Average Dividend Yield 44.35
Payout Ratio 470.54%
Dividend Date 3Dec 14, 2009
Ex-Dividend Date 4Sept 28, 2021
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Mar 30, 2022
Most Recent Quarter (mrq)Jun 29, 2022


Profit Margin 5.49%
Operating Margin (ttm)14.36%

Management Effectiveness

Return on Assets (ttm)2.41%
Return on Equity (ttm)3.42%

Income Statement

Revenue (ttm)3.59T
Revenue Per Share (ttm)1,152.26
Quarterly Revenue Growth (yoy)2.40%
Gross Profit (ttm)2.44T
Net Income Avi to Common (ttm)197.39B
Diluted EPS (ttm)0.53
Quarterly Earnings Growth (yoy)-23.70%

Balance Sheet

Total Cash (mrq)645.99B
Total Cash Per Share (mrq)208.91
Total Debt (mrq)4.6T
Total Debt/Equity (mrq)72.85
Current Ratio (mrq)1.18
Book Value Per Share (mrq)1,482.50

Cash Flow Statement

Operating Cash Flow (ttm)1.04T
Levered Free Cash Flow (ttm)779.94B